Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodies

Jinfeng Li1, Feihuan Hu1, Shouyi Chen2

  • 1Department of Transfusion Medicine, Southern Medical University, Guangzhou, China.

BMC Microbiology
|May 17, 2017
PubMed
Abstract

Insights

Researchers developed potent monoclonal antibodies targeting the Brucella outer membrane protein-31 (Omp31). These antibodies are crucial for accurately detecting and identifying Brucella species, aiding in the diagnosis of this severe zoonotic disease.

Area of Science:

  • Immunology
  • Microbiology
  • Veterinary Science

Background:

  • Brucellosis is a significant global zoonotic disease affecting both humans and animals.
  • Accurate detection and identification of Brucella species are critical for disease management.
  • The outer membrane protein-31 (Omp31) is a key antigen in Brucella, but its epitopes require further characterization.

Purpose of the Study:

  • To produce and characterize monoclonal antibodies (mAbs) against the Omp31 protein of Brucella melitensis.
  • To identify specific linear, semi-conformational, and conformational epitopes on Omp31.
  • To evaluate the diagnostic potential of generated mAbs for Brucella detection.

Main Methods:

  • Production of 22 monoclonal antibodies against Brucella melitensis Omp31.
  • Epitope mapping using various immunoassays to determine antibody binding characteristics.
  • Analysis of antibody isotypes (IgG2a, IgG1, IgM) and reactivity levels.
  • Testing antibody cross-reactivity with different Brucella species.

Main Results:

  • 13 mAbs recognized linear epitopes, 7 reacted with semi-conformational epitopes, and 2 recognized conformational epitopes.
  • Eight highly reactive mAbs (3 IgM, 5 IgG) were identified as potentially diagnostic.
  • Specific mAbs demonstrated reactivity with conserved epitopes across multiple Brucella species, including B. melitensis, B. ovis, B. suis, and B. canis.
  • One mAb (5H3) showed high reactivity with a conformational epitope on Omp31.

Conclusions:

  • Developed potent monoclonal antibodies targeting Brucella Omp31.
  • These antibodies can be utilized for the identification of Omp31 antigens.
  • The mAbs enable the detection of Brucella melitensis and other Brucella species (excluding B. abortus) in various settings.